Correlation Between Health Care and Biotechnology Portfolio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Care and Biotechnology Portfolio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Care and Biotechnology Portfolio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Care Portfolio and Biotechnology Portfolio Biotechnology, you can compare the effects of market volatilities on Health Care and Biotechnology Portfolio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Care with a short position of Biotechnology Portfolio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Care and Biotechnology Portfolio.

Diversification Opportunities for Health Care and Biotechnology Portfolio

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Health and Biotechnology is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Health Care Portfolio and Biotechnology Portfolio Biotec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Portfolio and Health Care is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Care Portfolio are associated (or correlated) with Biotechnology Portfolio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Portfolio has no effect on the direction of Health Care i.e., Health Care and Biotechnology Portfolio go up and down completely randomly.

Pair Corralation between Health Care and Biotechnology Portfolio

Assuming the 90 days horizon Health Care Portfolio is expected to generate 0.86 times more return on investment than Biotechnology Portfolio. However, Health Care Portfolio is 1.16 times less risky than Biotechnology Portfolio. It trades about -0.19 of its potential returns per unit of risk. Biotechnology Portfolio Biotechnology is currently generating about -0.17 per unit of risk. If you would invest  3,116  in Health Care Portfolio on October 6, 2024 and sell it today you would lose (340.00) from holding Health Care Portfolio or give up 10.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Health Care Portfolio  vs.  Biotechnology Portfolio Biotec

 Performance 
       Timeline  
Health Care Portfolio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Health Care Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Biotechnology Portfolio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Health Care and Biotechnology Portfolio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Care and Biotechnology Portfolio

The main advantage of trading using opposite Health Care and Biotechnology Portfolio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Care position performs unexpectedly, Biotechnology Portfolio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Portfolio will offset losses from the drop in Biotechnology Portfolio's long position.
The idea behind Health Care Portfolio and Biotechnology Portfolio Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities